InMed Pharmaceuticals (OTCMKTS:IMLFF – Get Rating) is one of 350 public companies in the “Biotechnology” industry, but how does it compare to its rivals? We will compare InMed Pharmaceuticals to similar companies based on the strength of its dividends, analyst recommendations, risk, earnings, institutional ownership, valuation and profitability. Analyst Ratings This is a breakdown of […]
InMed Pharmaceuticals (OTCMKTS:IMLFF – Get Rating) is one of 336 publicly-traded companies in the “Biotechnology” industry, but how does it contrast to its competitors? We will compare InMed Pharmaceuticals to related businesses based on the strength of its profitability, risk, valuation, analyst recommendations, earnings, dividends and institutional ownership. Analyst Recommendations This is a breakdown of […]
InMed Pharmaceuticals (OTCMKTS:IMLFF – Get Rating) is one of 365 public companies in the “Biotechnology” industry, but how does it contrast to its competitors? We will compare InMed Pharmaceuticals to similar businesses based on the strength of its valuation, institutional ownership, analyst recommendations, dividends, risk, earnings and profitability. Profitability This table compares InMed Pharmaceuticals and […]
Vancouver, British Columbia (Newsfile Corp. - June 1, 2023) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a leader in the pharmaceutical research, development, manufacturing
InMed s Neurodegenerative Disease Study Presented at Canadian Neuroscience Meeting streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.